1Bozzi Y, Casarosa S, Caleo M. Epilepsy as a neurodevelopmental dysfunction. Frontiers in psychiatry. 2012 Mar 19;3:19. doi: 10.3389/fpsyt.2012.00019.  

2Conrad J, Pawlowski M, Dogan M, et al. Seizures after cerebrovascular occasions: Threat elements and medical options. Seizure. 2013;22(4):275-82. doi:10.1016/j.seizure.2013.01.014.

3Wang J, Lin ZJ, Liu L, Xu HQ, Shi YW, Yi YH, He N, Liao WP. Epilepsy-associated genes. Seizure. 2017 Jan 1;44:11-20. doi: 10.1016/j.seizure.2016.11.030.

4Hellwinkel JE, Anderson FL, Trofa DP, Deitrich MP, Dansby JD, Noble JM, Bottiglieri TS. Submit-Traumatic Epilepsy after Sports activities-Associated Concussion: A Case Report. Neurotrauma Stories. 2020 Jul 1;1(1):42-5.

5Arends JB. Motionprimarily based seizure detection. Epilepsia. 2018 Jun;59:30-5. doi: 10.1111/epi.14053

6Fogarasi A, Tuxhorn I, Janszky J, Janszky I, Rásonyi G, Kelemen A, Halász P. Agedependent seizure semiology in temporal lobe epilepsy. Epilepsia. 2007 Sep;48(9):1697-702. doi: 10.1111/j.1528-1167.2007.01129.x

7Lee SI, Kirby D. Absence seizure with generalized rhythmic delta exercise. Epilepsia. 1988 Jun;29(3):262-7. doi: 10.1111/j.1528-1157.1988.tb03716.x

8Jenssen S, Gracely EJ, Sperling MR. How lengthy do most seizures final? A scientific comparability of seizures recorded within the epilepsy monitoring unit. Epilepsia. 2006 Sep;47(9):1499-503. doi: 10.1111/j.1528-1167.2006.00622.x

9Greenfield Jr LJ. Molecular mechanisms of antiseizure drug exercise at GABAA receptors. Seizure. 2013 Oct 1;22(8):589-600. doi: 10.1016/j.seizure.2013.04.015

10Bagshaw AP, Cavanna AE. Mind mechanisms of altered consciousness in focal seizures. Behavioural neurology. 2011 Jan 1;24(1):35-41. doi: 10.3233/BEN-2011-0312

11Wiebe S, Blume WT, Girvin JP, Eliasziw M. A randomized, managed trial of surgical procedure for temporal-lobe epilepsy. New England Journal of Drugs. 2001 Aug 2;345(5):311-8. doi: 10.1056/NEJM200108023450501

12Pohlmann-Eden B, Beghi E, Camfield C, Camfield P. The primary seizure and its administration in adults and youngsters. Bmj. 2006 Feb 9;332(7537):339-42. doi: 10.1136/bmj.332.7537.339

13Bozzi Y, Provenzano G, Casarosa S. Neurobiological bases of autism–epilepsy comorbidity: a concentrate on excitation/inhibition imbalance. European Journal of Neuroscience. 2018 Mar;47(6):534-48. doi: 10.1111/ejn.13595

14Porter RJ, Kupferberg HJ, Hessie BJ. Mechanisms of motion of anti-seizure medication and the anticonvulsant screening program of the Nationwide Institute of Neurological Problems and Stroke. Int J Clin Pharmacol Ther. 2015 Jan 1;53:9-12. doi: 10.5414/CP202212.

15Kalis MM, Huff NA. Oxcarbazepine, an antiepileptic agent. Scientific therapeutics. 2001 Might 1;23(5):680-700. doi: 10.1016/s0149-2918(01)80019-9. 

16Zou S, Kumar U. Cannabinoid receptors and the endocannabinoid system: signaling and performance within the central nervous system. Worldwide journal of molecular sciences. 2018 Mar;19(3):833. doi: 10.3390/ijms19030833

17Gu B, Zhu M, Glass MR, Rougié M, Nikolova VD, Moy SS, Carney PR, Philpot BD. Cannabidiol attenuates seizures and EEG abnormalities in Angelman syndrome mannequin mice. The Journal of medical investigation. 2019 Nov 4;129(12). doi: 10.1172/JCI130419

18Devinsky O, Patel AD, Cross JH, Villanueva V, Wirrell EC, Privitera M, Greenwood SM, Roberts C, Checketts D, VanLandingham KE, Zuberi SM. Impact of cannabidiol on drop seizures within the Lennox–Gastaut syndrome. New England Journal of Drugs. 2018 Might 17;378(20):1888-97. doi: 10.1056/NEJMoa1714631

19Devinsky O, Cilio MR, Cross H, FernandezRuiz J, French J, Hill C, Katz R, Di Marzo V, JutrasAswad D, Notcutt WG, MartinezOrgado J. Cannabidiol: pharmacology and potential therapeutic function in epilepsy and different neuropsychiatric problems. Epilepsia. 2014 Jun;55(6):791-802. doi: 10.1111/epi.12631